BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

168 related articles for article (PubMed ID: 11711629)

  • 1. Intracellular signaling molecules activated by Epstein-Barr virus for induction of interferon regulatory factor 7.
    Zhang L; Wu L; Hong K; Pagano JS
    J Virol; 2001 Dec; 75(24):12393-401. PubMed ID: 11711629
    [TBL] [Abstract][Full Text] [Related]  

  • 2. TRAF6 is a critical mediator of signal transduction by the viral oncogene latent membrane protein 1.
    Schultheiss U; Püschner S; Kremmer E; Mak TW; Engelmann H; Hammerschmidt W; Kieser A
    EMBO J; 2001 Oct; 20(20):5678-91. PubMed ID: 11598011
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Interferon regulatory factor 7 mediates activation of Tap-2 by Epstein-Barr virus latent membrane protein 1.
    Zhang L; Pagano JS
    J Virol; 2001 Jan; 75(1):341-50. PubMed ID: 11119603
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Matrix metalloproteinase 9 expression is induced by Epstein-Barr virus latent membrane protein 1 C-terminal activation regions 1 and 2.
    Takeshita H; Yoshizaki T; Miller WE; Sato H; Furukawa M; Pagano JS; Raab-Traub N
    J Virol; 1999 Jul; 73(7):5548-55. PubMed ID: 10364303
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Structure and function of IRF-7.
    Zhang L; Pagano JS
    J Interferon Cytokine Res; 2002 Jan; 22(1):95-101. PubMed ID: 11846980
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Epstein-Barr virus-encoded LMP1 and CD40 mediate IL-6 production in epithelial cells via an NF-kappaB pathway involving TNF receptor-associated factors.
    Eliopoulos AG; Stack M; Dawson CW; Kaye KM; Hodgkin L; Sihota S; Rowe M; Young LS
    Oncogene; 1997 Jun; 14(24):2899-916. PubMed ID: 9205097
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Multiple signal transducers and activators of transcription are induced by EBV LMP-1.
    Zhang L; Hong K; Zhang J; Pagano JS
    Virology; 2004 May; 323(1):141-52. PubMed ID: 15165826
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Transactivation of CCL20 gene by Epstein-Barr virus latent membrane protein 1.
    Okudaira T; Yamamoto K; Kawakami H; Uchihara JN; Tomita M; Masuda M; Matsuda T; Sairenji T; Iha H; Jeang KT; Matsuyama T; Takasu N; Mori N
    Br J Haematol; 2006 Feb; 132(3):293-302. PubMed ID: 16409294
    [TBL] [Abstract][Full Text] [Related]  

  • 9. CD40 and LMP-1 both signal from lipid rafts but LMP-1 assembles a distinct, more efficient signaling complex.
    Kaykas A; Worringer K; Sugden B
    EMBO J; 2001 Jun; 20(11):2641-54. PubMed ID: 11387199
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Repression of Smad-dependent transforming growth factor-beta signaling by Epstein-Barr virus latent membrane protein 1 through nuclear factor-kappaB.
    Mori N; Morishita M; Tsukazaki T; Yamamoto N
    Int J Cancer; 2003 Jul; 105(5):661-8. PubMed ID: 12740915
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Interferon regulatory factor 7 is associated with Epstein-Barr virus-transformed central nervous system lymphoma and has oncogenic properties.
    Zhang L; Zhang J; Lambert Q; Der CJ; Del Valle L; Miklossy J; Khalili K; Zhou Y; Pagano JS
    J Virol; 2004 Dec; 78(23):12987-95. PubMed ID: 15542650
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Interferon regulatory factor 7: a key cellular mediator of LMP-1 in EBV latency and transformation.
    Zhang L; Pagano JS
    Semin Cancer Biol; 2001 Dec; 11(6):445-53. PubMed ID: 11669606
    [TBL] [Abstract][Full Text] [Related]  

  • 13. EBV latent membrane protein-1 protects B cells from apoptosis by inhibition of BAX.
    Grimm T; Schneider S; Naschberger E; Huber J; Guenzi E; Kieser A; Reitmeir P; Schulz TF; Morris CA; Stürzl M
    Blood; 2005 Apr; 105(8):3263-9. PubMed ID: 15613549
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Latent membrane protein 1 of Epstein-Barr virus inhibits as well as stimulates gene expression.
    Sandberg ML; Kaykas A; Sugden B
    J Virol; 2000 Oct; 74(20):9755-61. PubMed ID: 11000250
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Epstein-Barr virus regulates STAT1 through latent membrane protein 1.
    Richardson C; Fielding C; Rowe M; Brennan P
    J Virol; 2003 Apr; 77(7):4439-43. PubMed ID: 12634403
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The latent membrane protein 1 of Epstein-Barr virus (EBV) primes EBV latency cells for type I interferon production.
    Xu D; Brumm K; Zhang L
    J Biol Chem; 2006 Apr; 281(14):9163-9. PubMed ID: 16469740
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Dual functions of interferon regulatory factors 7C in Epstein-Barr virus-mediated transformation of human B lymphocytes.
    Zhao Y; Xu D; Jiang Y; Zhang L
    PLoS One; 2010 Mar; 5(3):e9459. PubMed ID: 20209099
    [TBL] [Abstract][Full Text] [Related]  

  • 18. The Epstein-Barr virus latent membrane protein-1 (LMP1) mediates activation of NF-kappa B and cell surface phenotype via two effector regions in its carboxy-terminal cytoplasmic domain.
    Huen DS; Henderson SA; Croom-Carter D; Rowe M
    Oncogene; 1995 Feb; 10(3):549-60. PubMed ID: 7845680
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Interferon regulatory factor 4 is involved in Epstein-Barr virus-mediated transformation of human B lymphocytes.
    Xu D; Zhao L; Del Valle L; Miklossy J; Zhang L
    J Virol; 2008 Jul; 82(13):6251-8. PubMed ID: 18417578
    [TBL] [Abstract][Full Text] [Related]  

  • 20. A novel dominant-negative mutant form of Epstein-Barr virus latent membrane protein-1 (LMP1) selectively and differentially impairs LMP1 and TNF signaling pathways.
    Adriaenssens E; Mougel A; Goormachtigh G; Loing E; Fafeur V; Auriault C; Coll J
    Oncogene; 2004 Apr; 23(15):2681-93. PubMed ID: 14767477
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.